Abstract
Background: DDX3 is a protein with RNA helicase activity that is involved in a variety of biological processes, and it is an important protein target for the development of broad-spectrum antiviral drugs, multiple cancers and chronic inflammation.
Objectives: The objective of this study is to establish a simple and efficient method to express and purify DDX3 protein in E. coli, and the recombinant DDX3 should maintain helicase activity for further tailor-made screening and biochemical function validation.
Methods: DDX3 cDNA was simultaneously cloned into pET28a-TEV and pNIC28-Bsa4 vectors and transfected into E. coli BL21 (DE3) to compare one suitable prokaryotic expression system. The 6×His-tag was fused to the C-terminus of DDX3 to form a His-tagging DDX3 fusion protein for subsequent purification. Protein dissolution buffer and purification washing conditions were optimized. The His-tagged DDX3 protein would bind with the Ni-NTA agarose by chelation and collected by affinity purification. The 6×His-tag fused with N-terminal DDX3 was eliminated from DDX3 by TEV digestion. A fine purification of DDX3 was performed by gel filtration chromatography.
Results: The recombinant plasmid pNIC28-DDX3, which contained a 6×His-tag and one TEV cleavage site at the N terminal of DDX3 sequence, was constructed for DDX3 prokaryotic expression and affinity purification based on considering the good solubility of the recombinant His-tagging DDX3, especially under 0.5 mM IPTG incubation at 18°C for 18 h to obtain more soluble DDX3 protein. Finally, the exogenous recombinant DDX3 protein was obtained with more than 95% purity by affinity purification on the Ni-NTA column and removal of miscellaneous through gel filtration chromatography. The finely-purified DDX3 still retained its ATPase activity.
Conclusion: A prokaryotic expression pNIC28-DDX3 system is constructed for efficient expression and affinity purification of bioactive DDX3 protein in E. coli BL21(DE3), which provides an important high-throughput screening and validation of drugs targeting DDX3.
Keywords: DDX3, Prokaryotic expression, affinity purification, ATPase activity, His-tag, Ni-NTA column.
[http://dx.doi.org/10.1038/nrm3154] [PMID: 21779027]
[http://dx.doi.org/10.1002/wrna.1165] [PMID: 23606618]
[http://dx.doi.org/10.3389/fcell.2022.1033684] [PMID: 36393867]
[http://dx.doi.org/10.1016/j.bbagrm.2016.03.009] [PMID: 27012366]
[http://dx.doi.org/10.1186/s12943-021-01325-7] [PMID: 33627125]
[http://dx.doi.org/10.1093/nar/gkn454] [PMID: 18628297]
[http://dx.doi.org/10.1038/sj.onc.1210687] [PMID: 17667941]
[http://dx.doi.org/10.1038/s41467-019-11083-2] [PMID: 31300642]
[http://dx.doi.org/10.1158/0008-5472.CAN-05-2415] [PMID: 16818630]
[http://dx.doi.org/10.3892/or.2018.6203] [PMID: 29328432]
[http://dx.doi.org/10.1038/s41586-019-1551-2] [PMID: 31511697]
[http://dx.doi.org/10.1016/j.neuron.2020.01.042] [PMID: 32135084]
[http://dx.doi.org/10.1038/s41467-021-22608-z] [PMID: 33931637]
[PMID: 30373933]
[http://dx.doi.org/10.1158/0008-5472.CAN-20-3790] [PMID: 33941613]
[http://dx.doi.org/10.1038/sj.onc.1209239] [PMID: 16301996]
[http://dx.doi.org/10.1016/j.bbamcr.2011.01.003] [PMID: 21237216]
[http://dx.doi.org/10.3390/ijms160715578] [PMID: 26184164]
[http://dx.doi.org/10.1097/PAI.0000000000000422] [PMID: 29621097]
[http://dx.doi.org/10.1038/onc.2015.336] [PMID: 26364611]
[http://dx.doi.org/10.1056/NEJMoa1109016] [PMID: 22150006]
[http://dx.doi.org/10.1111/bjh.13211] [PMID: 25382417]
[PMID: 23330003]
[http://dx.doi.org/10.1155/2015/379568] [PMID: 26294807]
[http://dx.doi.org/10.1091/mbc.e07-12-1264] [PMID: 18596238]
[http://dx.doi.org/10.1007/s00018-017-2503-3] [PMID: 28314893]
[http://dx.doi.org/10.1038/35050625] [PMID: 11146633]
[http://dx.doi.org/10.3390/v12091014] [PMID: 32932882]
[http://dx.doi.org/10.1158/0008-5472.CAN-16-0440] [PMID: 27634756]
[http://dx.doi.org/10.1038/nrd1853] [PMID: 16184083]
[http://dx.doi.org/10.15252/emmm.201404368] [PMID: 25820276]
[http://dx.doi.org/10.1002/cmdc.201100166] [PMID: 21698775]
[http://dx.doi.org/10.1038/srep09982] [PMID: 25918862]
[http://dx.doi.org/10.1016/j.bbrc.2019.12.094] [PMID: 31954521]
[http://dx.doi.org/10.1021/jm800332m] [PMID: 18680273]
[http://dx.doi.org/10.1021/acsmedchemlett.9b00681] [PMID: 32435411]
[http://dx.doi.org/10.1021/acs.jmedchem.8b01403] [PMID: 30721061]
[http://dx.doi.org/10.1016/j.ejmech.2020.112319] [PMID: 32446036]
[http://dx.doi.org/10.3390/cells9010170] [PMID: 31936642]
[http://dx.doi.org/10.1002/rmv.1845] [PMID: 26174373]
[http://dx.doi.org/10.1042/BST0390679] [PMID: 21428961]
[http://dx.doi.org/10.1016/j.antiviral.2020.104750] [PMID: 32205137]
[http://dx.doi.org/10.3390/molecules25041015] [PMID: 32102413]
[http://dx.doi.org/10.3390/molecules24213988] [PMID: 31690062]
[http://dx.doi.org/10.1073/pnas.1522987113] [PMID: 27118832]
[http://dx.doi.org/10.3389/fmicb.2022.959577] [PMID: 36090095]
[http://dx.doi.org/10.18632/oncotarget.23323] [PMID: 29383159]
[http://dx.doi.org/10.1038/s41419-019-1825-5] [PMID: 31391454]
[http://dx.doi.org/10.1111/1751-7915.13736] [PMID: 33369164]
[http://dx.doi.org/10.1016/j.jmb.2007.06.050] [PMID: 17631897]
[http://dx.doi.org/10.3109/10409238.2014.931339] [PMID: 25039764]
[http://dx.doi.org/10.1074/jbc.M115.700625] [PMID: 26598523]
[http://dx.doi.org/10.1016/j.jmb.2015.02.015] [PMID: 25724843]
[http://dx.doi.org/10.1038/s41589-018-0180-7] [PMID: 30531905]
[http://dx.doi.org/10.1016/j.str.2009.09.005] [PMID: 19913487]
[http://dx.doi.org/10.3390/cells8101181] [PMID: 31575075]
[http://dx.doi.org/10.1042/BJ20110739] [PMID: 21883093]
[http://dx.doi.org/10.1038/emboj.2012.220] [PMID: 22872150]
[http://dx.doi.org/10.1128/MCB.01603-12] [PMID: 23478265]
[http://dx.doi.org/10.1042/BCJ20160956] [PMID: 27980081]
[http://dx.doi.org/10.4049/jimmunol.1400199] [PMID: 24829406]
[http://dx.doi.org/10.1107/S2053230X14000430] [PMID: 24637767]
[http://dx.doi.org/10.1186/s12934-021-01698-w] [PMID: 34717620]
[http://dx.doi.org/10.1007/s11095-016-2078-y] [PMID: 27981449]
[http://dx.doi.org/10.1016/j.ijpharm.2019.118568] [PMID: 31352055]
[http://dx.doi.org/10.1016/j.foodchem.2021.129620] [PMID: 33780795]
[http://dx.doi.org/10.1080/07388551.2020.1742646] [PMID: 32202164]
[http://dx.doi.org/10.1016/S0076-6879(09)63002-0] [PMID: 19892162]
[http://dx.doi.org/10.1107/S0907444903024491] [PMID: 14684931]
[http://dx.doi.org/10.1021/bi900649t] [PMID: 19817484]
[http://dx.doi.org/10.2174/092986711793979698] [PMID: 21110818]
[http://dx.doi.org/10.1021/bp0498793] [PMID: 15458311]
[http://dx.doi.org/10.1002/btpr.93] [PMID: 19194951]
[http://dx.doi.org/10.1007/s00726-007-0506-3] [PMID: 17357829]
![Wayfinder Image](/images/wayfinder.jpg)